Across its top 20 institutional holders, QGEN's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 11/100, avg. turnover score 29/100).

Quarterly Activity

Recent Activity

+$4.5B

Total Buy Value

$6.4B

Total Sell Value

New buy315

Trim17

Add9

Sold out293

324

Net Buyers

310

Net Sellers

Smart Money Convergence

QGEN does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/QGEN

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

N72482156, N72482107, N72482123, N72482149, N72482206, N72482AA5, N72482AT4

FAQ

Who are the top institutional investors holding Qiagen N.V. (QGEN)?

Major stakeholders currently include Wellington Management Group LLP ($575.1M), Price T Rowe Associates INC /md/ ($337.5M), Vanguard Capital Management LLC ($247.4M). Based on the latest 13F filings, there are a total of 352 tracked investment funds and institutions maintaining positions in QGEN.

What is the overall institutional sentiment toward QGEN recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $4.4B, driven by 324 managers accumulating shares while 310 reduced their exposure.

Which institutions have been selling or reducing their QGEN positions?

In the latest period, 17 funds trimmed their holdings, and 293 managers completely exited their positions. The aggregate reported sell value was $6.4B.

Are there any notable investors adding QGEN to their portfolios?

Yes, buying activity remains notable. 315 institutions opened new positions in {ticker}, and 9 existing holders added to their shares. The total reported buy value for the quarter amounted to $4.5B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,604

Total reported value

$438.9B

291 institutions currently hold both QGEN and this stock

View detail

LLY

Eli Lilly & Co

Institutions Holding

4,338

Total reported value

$730.5B

301 institutions currently hold both QGEN and this stock

View detail

ABBV

Abbvie INC

Institutions Holding

4,025

Total reported value

$283.9B

291 institutions currently hold both QGEN and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,151

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail

AMZN

Amazon.com INC

Institutions Holding

5,958

Total reported value

$1.5T

3029 13F institutions increased their position this quarter

View detail

NVDA

Nvidia CORP

Institutions Holding

5,766

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access QGEN's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/QGEN

CLI

npx alphasmo stocks get QGEN

Full API & MCP documentation →